Prior studies had shown that CCR5 induces cancer cell homing to metastatic sites [12, 55], augments the pro-inflammatory pro-metastatic immune phenotype [46], and enhances DNA repair [13], providing aberrant cell survival and resistance to DNA-damaging agents. This evidence concerns the gene CCR5 and cancer.